nuzefatide pevedotin
nuzefatide pevedotin: developed by 1 company · 3 clinical trials tracked.
nuzefatide pevedotin evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
How could nuzefatide pevedotin → BCYC affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence8 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (2)
| Company | Phase |
|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) advanced solid tumors and recurrent metastatic pancreatic du… | Phase 2 |
| BICYCLE THERAPEUTICS PLC (BCYC) Advanced Solid Tumor Historically Known for High EphA2 Expre… | Phase 2 |
Clinical Trials (3)
Bicycle Continued Access Protocol (BiCAP) for Participants Receiving a Bicycle Investigational Product on a BicycleTx Limited-Sponsored Study
Primary endpoint: Monitor safety for participants receiving a Bicycle investigational product
A Phase 2 Study of BT5528 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Primary endpoint: Objective Response Rate (ORR)
Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT5528 in Patients With Advanced Malignancies Associated With EphA2 Expression
Primary endpoint: Part A-1 and A-2(escalations): Number of participants receiving BT5528 alone and in combination with nivolumab with treatment-emergent adverse events
Frequently asked questions
Who is developing nuzefatide pevedotin?
nuzefatide pevedotin is being developed by BICYCLE THERAPEUTICS PLC.
How many clinical trials involve nuzefatide pevedotin?
BioSniper tracks 3 clinical trials involving nuzefatide pevedotin.